Steve at last is offered a top job in the new merged company, which soon will become the biggest pharmaceutical corporation in the world, but hours later his new boss is dead. It could be an accident but suspicions are raised by the odd behavior of the CEO and his Security Head. Meanwhile the final trials on the West Coast of a potential blockbuster cancer drug hit a snag, threatening the merger itself. Steve is drawn into the investigation...